Drug Combo Lowers Albuminuria in High-Risk Chronic Kidney Disease

By News Health
43 minutes Ago

(MedPage Today) — HOUSTON — Adding an investigational nonsteroidal mineralocorticoid receptor antagonist (MRA) to an SGLT2 inhibitor led to a superior reduction in albuminuria among chronic kidney disease patients at risk for kidney failure…

Source link : https://www.medpagetoday.com/meetingcoverage/asn/118439

Author :

Publish date : 2025-11-11 15:58:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Investigational GLP-1-Based Drug Hits MASH Resolution Mark, Misses Fibrosis Target

DNA Points to Suspect in Nurse's Murder; Shutdown End in Sight; Young Women With ALS

Odds of asteroid 2024 YR4 hitting the moon may rise to 30 per cent

Hospital trust fined £500k over death of patient Alice Figueiredo

Life as an American Expat Physician

Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk